Atea Pharmaceuticals, Inc. (AVIR) Accounts Receivable, after Allowance for Credit Loss, Current USD 2021 - 2022

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary: Atea Pharmaceuticals, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from 2021 to 2022.
Atea Pharmaceuticals, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending September 30, 2022 was $4.51 M.

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2022	$4.51 M			Sep 30, 2022	10-Q	2022-11-07
Q2 2021	$50 M			Jun 30, 2021	10-Q	2021-08-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.